Timothy D McClure
Overview
Explore the profile of Timothy D McClure including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramaswamy A, Hung M, Pelt J, Iranmahboub P, Calderon L, Scherr I, et al.
PLoS One
. 2025 Jan;
19(12):e0314989.
PMID: 39775249
Purpose: Implicit, unconscious biases in medicine are personal attitudes about race, ethnicity, gender, and other characteristics that may lead to discriminatory patterns of care. However, there is no consensus on...
2.
George A, Miocinovic R, Patel A, Lomas D, Correa A, Chen D, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927884
The PRESERVE study (NCT04972097) aims to evaluate the safety and effectiveness of the NanoKnife System to ablate prostate tissue in patients with intermediate-risk prostate cancer (PCa). The NanoKnife uses irreversible...
3.
Mouli S, Salem R, McClure T
J Urol
. 2024 May;
212(1):216-219.
PMID: 38703386
No abstract available.
4.
Zhu A, Strasser M, McClure T, Gereta S, Cheng E, Pandit K, et al.
Eur Urol Focus
. 2024 Apr;
10(5):843-850.
PMID: 38677913
Background And Objective: There is an absence of high-level evidence comparing oncologic endpoints for partial gland ablation, and most series use prostate-specific antigen (PSA) rather than biopsy endpoints. Our aim...
5.
Hung M, Ross A, Li E, Pavlovich C, Fletcher S, Gereta S, et al.
Urology
. 2024 Feb;
186:91-97.
PMID: 38387509
Objective: To compare clinically significant prostate cancer detection with TP-TBx utilizing software vs cognitive fusion. It is established that MRI prior to prostate biopsy improves detection of clinically significant cancer...
6.
Smirniotopoulos J, Jain N, Sens J, Deolankar J, Marchalik D, McClure T, et al.
J Vasc Interv Radiol
. 2022 Dec;
34(4):653-659.
PMID: 36521792
Purpose: This study aimed to assess the safety and efficacy of percutaneous lithotripsy for gallstone eradication in patients with calculous cholecystitis with stones >1 cm. Materials And Methods: Multi-institutional institutional...
7.
Ehdaie B, Tempany C, Holland F, Sjoberg D, Kibel A, Trinh Q, et al.
Lancet Oncol
. 2022 Jun;
23(7):910-918.
PMID: 35714666
Background: Men with grade group 2 or 3 prostate cancer are often considered ineligible for active surveillance; some patients with grade group 2 prostate cancer who are managed with active...
8.
McClure T, Ortiz A, Doustaly R, Rocha A, Moreira A, de Assis A, et al.
Cardiovasc Intervent Radiol
. 2022 Feb;
45(6):884-887.
PMID: 35149885
No abstract available.
9.
Basourakos S, Al Hussein Al Awamlh B, Bianco F, Patel N, Laviana A, Margolis D, et al.
BMJ Surg Interv Health Technol
. 2022 Jan;
2(1):e000056.
PMID: 35047795
Objectives: Cryoablation for prostate cancer is typically performed under general anaesthesia. We explore the safety, feasibility and costs of in-office MRI-targeted prostate partial gland cryoablation (PGC) under local anaesthesia. We...
10.
Wadhwa V, McClure T
Semin Roentgenol
. 2021 Oct;
56(4):410-415.
PMID: 34688344
No abstract available.